VUVA VAGINAL DILATORS VS. PLACEBO DILATORS: A DOUBLE BLIND PLACEBO STUDY
Eighty percent (80%) of study subjects reported a decrease in overall pain after using the VuVa™ magnetic vaginal dilators.
Subjects using the VuVa™ magnetic vaginal dilators experienced an average thirty percent (30%) decrease in pain levels on a standardized tampon test, which is a way to clinically measure pain associated with sexual intercourse.
The cotton swab test evaluates eleven (11) different locations of the vulvar vestibule for pain. Eighty percent (80%) of the study subjects reported a decrease in the total number of locations after using the VuVa™ magnetic vaginal dilators.
Subjects using the VuVa™ magnetic vaginal dilators experienced an average twenty eight percent (28%) decrease in pain levels using a standardized cotton swab test, which is a non-invasive measure of vaginal pain.
Overall anxiety associated with vaginal penetration is significantly decreased in all subjects.
Subjects report feeling more confident about their sexual health in the future after completing the study.
Subjects report that VuVa dilator therapy is not a painful treatment.
PHYSICIAN CARE CLINICAL RESEARCH
Physician Care Clinical Research is located in Sarasota, Florida and has been conducting clinical research trials in women's health since 2008. The Principal Investigator on the VuVa™ magnetic vaginal dilator clinical study was Dr. Michael Swor, MD who has over 20 years of clinical research experience and has been consistently listed in the Castle-Connelly Top Doctors in America, the Suncoast Best™, BestDoctor™, and Best ObGyns in America.
VUVA CLINICAL TRIAL CHIEF INVESTIGATOR - DR. MICHAEL SWOR
Dr. G. Michael Swor is an obstetrician-gynecologist in Sarasota, Florida and is affiliated with multiple hospitals in the area, including Doctors Hospital of Sarasota and Sarasota Memorial Health Care System. He received his medical degree from University of South Florida College of Medicine and has been in practice for 34 years. Please email email@example.com to obtain full clinical trial report.